Dow Jones

40,211.72

0.53%

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

(MM) (IDIX)

(MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IDIX

<< Previous 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next >>

Date	Time	Source	Headline	Symbol	Company
13/11/2009	19:07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/A)	NASDAQ:IDIX	(MM)
03/11/2009	13:00	PR Newswire (US)	Idenix Pharmaceuticals Initiates Phase II Clinical Trial of IDX184 in Combination With Pegylated Interferon and Ribavirin for th	NASDAQ:IDIX	(MM)
30/10/2009	12:00	PR Newswire (US)	Idenix Pharmaceuticals Presents Data on IDX184 for the Treatment of Hepatitis C Virus (HCV)	NASDAQ:IDIX	(MM)
29/10/2009	20:19	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:IDIX	(MM)
29/10/2009	20:15	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
29/10/2009	20:05	PR Newswire (US)	Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2009 Financial Results	NASDAQ:IDIX	(MM)
29/10/2009	20:05	PR Newswire (US)	Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV	NASDAQ:IDIX	(MM)
27/10/2009	20:05	PR Newswire (US)	Idenix Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference	NASDAQ:IDIX	(MM)
22/10/2009	21:05	PR Newswire (US)	Idenix to Host Conference Call Discussing Third Quarter 2009 Financial Results	NASDAQ:IDIX	(MM)
01/10/2009	21:05	PR Newswire (US)	Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASL	NASDAQ:IDIX	(MM)
28/09/2009	21:05	PR Newswire (US)	Idenix Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference	NASDAQ:IDIX	(MM)
03/09/2009	21:05	PR Newswire (US)	Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences	NASDAQ:IDIX
01/09/2009	21:27	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:IDIX	(MM)
24/08/2009	21:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
05/08/2009	22:05	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
05/08/2009	21:45	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(5) (424B5)	NASDAQ:IDIX	(MM)
05/08/2009	14:15	PR Newswire (US)	Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock	NASDAQ:IDIX	(MM)
20/07/2009	21:16	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
20/07/2009	21:05	PR Newswire (US)	Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results	NASDAQ:IDIX	(MM)
20/07/2009	21:05	PR Newswire (US)	Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)	NASDAQ:IDIX	(MM)
14/07/2009	21:05	PR Newswire (US)	Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results	NASDAQ:IDIX	(MM)
11/06/2009	21:00	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IDIX	(MM)
03/06/2009	22:00	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3)	NASDAQ:IDIX	(MM)
03/06/2009	21:04	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDIX	(MM)
03/06/2009	20:51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
03/06/2009	20:48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
03/06/2009	20:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
03/06/2009	20:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
03/06/2009	20:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
29/05/2009	20:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)